Literature DB >> 8593030

Activities of oral antibiotics on Providencia strains isolated from institutionalized elderly patients with urinary tract infections.

G Cornaglia1, S Frugoni, A Mazzariol, E Piacentini, A Berlusconi, R Fontana.   

Abstract

More than 250 Providencia strains isolated from the urine of institutionalized elderly patients were tested against cefaclor, cefuroxime, cefetamet, cefpodoxime, ciprofloxacin, and amoxicillin-clavulanic acid. Our results confirm the strong activities of expanded-spectrum oral cephalosporins against Providencia isolates, f1p4ell as the marked differences in susceptibilities among accurately identified Providencia species.

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 8593030      PMCID： PMC163040          DOI： 10.1128/AAC.39.12.2819

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  17 in total

1.  Interaction with CEP-1 beta-lactamase of RU 51746-2, the active form of the new oral cephalosporin RU 51807.

Authors:  C Dusi; M Mistretta; G Cornaglia; R Fontana
Journal:  J Chemother       Date:  1991-01       Impact factor: 1.714

Review 2.  Providencia stuartii: a common cause of antibiotic-resistant bacteriuria in patients with long-term indwelling catheters.

Authors:  J W Warren
Journal:  Rev Infect Dis       Date:  1986 Jan-Feb

Review 3.  Providencia stuartii: a review of a multiply antibiotic-resistant bacterium.

Authors:  P M Hawkey
Journal:  J Antimicrob Chemother       Date:  1984-03       Impact factor: 5.790

4.  Comparative in vitro activity of semisynthetic penicillins against Proteeae.

Authors:  P M Hawkey; S J Pedler; A Turner
Journal:  Antimicrob Agents Chemother       Date:  1983-04       Impact factor: 5.191

5.  Comparable evaluation of orally active beta-lactam compounds in ampicillin-resistant gram-positive and gram-negative rods: role of beta-lactamases on resistance.

Authors:  W Cullmann; W Dick; M Stieglitz; W Opferkuch
Journal:  Chemotherapy       Date:  1988       Impact factor: 2.544

6.  Adherence to uroepithelial cells of Providencia stuartii isolated from the catheterized urinary tract.

Authors:  H L Mobley; G R Chippendale; J H Tenney; J W Warren
Journal:  J Gen Microbiol       Date:  1986-10

7.  Infections among patients in nursing homes: policies, prevalence, problems.

Authors:  R A Garibaldi; S Brodine; S Matsumiya
Journal:  N Engl J Med       Date:  1981-09-24       Impact factor: 91.245

8.  Commercial identification systems often fail to identify Providencia stuartii.

Authors:  G Cornaglia; B Dainelli; F Berlutti; M C Thaller
Journal:  J Clin Microbiol       Date:  1988-02       Impact factor: 5.948

9.  Species differences in susceptibilities of Proteeae spp. to six cephalosporins and three aminoglycosides.

Authors:  J L Penner; M A Preston; J N Hennessy; L J Barton; M M Goodbody
Journal:  Antimicrob Agents Chemother       Date:  1982-08       Impact factor: 5.191

10.  MR/K hemagglutination of Providencia stuartii correlates with adherence to catheters and with persistence in catheter-associated bacteriuria.

Authors:  H L Mobley; G R Chippendale; J H Tenney; A R Mayrer; L J Crisp; J L Penner; J W Warren
Journal:  J Infect Dis       Date:  1988-02       Impact factor: 5.226
View more
  8 in total

Review 1.  Classification, identification, and clinical significance of Proteus, Providencia, and Morganella.

Authors:  C M O'Hara; F W Brenner; J M Miller
Journal:  Clin Microbiol Rev       Date:  2000-10       Impact factor: 26.132

2.  Ceftazidime and aztreonam resistance in Providencia stuartii: characterization of a natural TEM-derived extended-spectrum beta-lactamase, TEM-60.

Authors:  N Franceschini; M Perilli; B Segatore; D Setacci; G Amicosante; A Mazzariol; G Cornaglia
Journal:  Antimicrob Agents Chemother       Date:  1998-06       Impact factor: 5.191

3.  Isolation and Molecular Identification and Antimicrobial Susceptibility of Providencia spp. from Raw Cow's Milk in Baghdad, Iraq.

Authors:  Nagham Mohammed Ayyal Al-Gburi
Journal:  Vet Med Int       Date:  2020-11-19

4.  Evaluation of current activities of fluoroquinolones against gram-negative bacilli using centralized in vitro testing and electronic surveillance.

Authors:  D F Sahm; I A Critchley; L J Kelly; J A Karlowsky; D C Mayfield; C Thornsberry; Y R Mauriz; J Kahn
Journal:  Antimicrob Agents Chemother       Date:  2001-01       Impact factor: 5.191

5.  A Case of Wound Infection with Providencia rettgeri and Coincident Gout in a Patient from Guam.

Authors:  Michael A Washington; Jason Barnhill; Jaclyn M Griffin
Journal:  Hawaii J Med Public Health       Date:  2015-11

6.  Providencia Rettgeri: An Emerging Nosocomial Uropathogen in an Indwelling Urinary Catheterised Patient.

Authors:  Siddharth Sagar; Nagalakshmi Narasimhaswamy; Jessica D'Souza
Journal:  J Clin Diagn Res       Date:  2017-06-01

7.  First case report of Providencia Rettgeri neonatal sepsis.

Authors:  Deepak Sharma; Pradeep Sharma; Priyanka Soni
Journal:  BMC Res Notes       Date:  2017-10-30

8.  Providencia in retail meats from Guangzhou, China and Osaka, Japan: prevalence, antimicrobial resistance and characterization of classes 1, 2 and 3 integrons.

Authors:  Huiling DI; Sisi Liang; Qingyang Li; Lei Shi; Ayaka Shima; Hecheng Meng; He Yan; Shinji Yamasaki
Journal:  J Vet Med Sci       Date:  2018-03-19       Impact factor: 1.267
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.